TB lesions in the lungs have high levels of proteins that suppress the immune system. Cancer drugs that target these proteins could be used to fight the bacterial infection.

It is no surprise that the World Health Organization (WHO) is calling for oxygen and critical medical supplies to safely reach those who need them in Ukraine and moving to establish safe transit for shipments through Poland. But nor is the call new. We’ve been here before.

A systematic analysis, published in The Lancet Microbe, presented the first catalogue, endorsed by the World Health Organization (WHO), of molecular targets for Mycobacterium tuberculosis complex drug susceptibility testing, intended to provide a global standard for resistance interpretation. The existence of this catalogue is expected to encourage the implementation of molecular diagnostics by national TB programs.

The Russian invasion of Ukraine could be “devastating” for tuberculosis control in eastern Europe, and will cause a “terrible public health tragedy”, Dr Anthony Fauci has warned.

Boston-based Massachusetts General Hospital (MGH), in partnership with NYU Langone Health, announced on March 1, 2022, a multi-center phase 2 clinical trial has launched to investigate a new BCG vaccine treatment for pediatric type 1 diabetes, even in subjects with established disease.

March 2, 2022 -- Tuberculosis (TB) can be consistently detected on lateral chest x-rays by an ensemble of two different types of deep-learning networks, according to research published online February 24 in Frontiers in Genomics.

A report from the Stop TB Partnership and Treatment Action Group in December highlighted the woefully inadequate funding allocated to tuberculosis research. Priya Venkatesan reports.

On 7 March 2022, on the eve of International Women's Day, the Global Coalition of TB Activists (GCTA) and partners will host a webinar to discuss how to address gender and stigma challenges to TB elimination.

The 6th Global Forum on TB Vaccines was held virtually on 22-25 February 2022. Professor Mark Hatherill, director of the South African TB Vaccine Initiative, addressed the Forum in a session on New Horizons for TB vaccines, warning that the TB vaccine pipeline is depleted with little progress of candidate vaccines through the pipeline in the last few years, creating a serious problem for the next decade of vaccine development.

RESIST-TB released its February 2022 newsletter with the latest research publications on drug-resistant TB.